489 related articles for article (PubMed ID: 17098441)
1. Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists.
Hurria A; Naeim A; Elkin E; Limaye S; Grover A; Hudis C; Pearce C; Robson M
Crit Rev Oncol Hematol; 2007 Mar; 61(3):255-60. PubMed ID: 17098441
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
3. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
[TBL] [Abstract][Full Text] [Related]
4. Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients.
DeMichele A; Putt M; Zhang Y; Glick JH; Norman S
Cancer; 2003 May; 97(9):2150-9. PubMed ID: 12712466
[TBL] [Abstract][Full Text] [Related]
5. Physicians' assessments of adjuvant tamoxifen's effectiveness in older patients with primary breast cancer.
Lash TL; Gurwitz JH; Silliman RA
J Am Geriatr Soc; 2005 Nov; 53(11):1889-96. PubMed ID: 16274369
[TBL] [Abstract][Full Text] [Related]
6. Attitudes of Canadian radiation oncologists towards post-lumpectomy radiotherapy for elderly women with stage I hormone-responsive breast cancer.
Warner E; Chow E; Fairchild A; Franssen E; Paszat L; Szumacher E
Clin Oncol (R Coll Radiol); 2010 Mar; 22(2):97-106. PubMed ID: 19883996
[TBL] [Abstract][Full Text] [Related]
7. Lost opportunities: physicians' reasons and disparities in breast cancer treatment.
Bickell NA; LePar F; Wang JJ; Leventhal H
J Clin Oncol; 2007 Jun; 25(18):2516-21. PubMed ID: 17577028
[TBL] [Abstract][Full Text] [Related]
8. Do age and ethnicity predict breast cancer treatment received? A cross-sectional urban population based study. Breast cancer treatment: age and ethnicity.
Naeim A; Hurria A; Leake B; Maly RC
Crit Rev Oncol Hematol; 2006 Sep; 59(3):234-42. PubMed ID: 16829122
[TBL] [Abstract][Full Text] [Related]
9. Physicians' reasons for failing to deliver effective breast cancer care: a framework for underuse.
Bickell NA; McEvoy MD
Med Care; 2003 Mar; 41(3):442-6. PubMed ID: 12618647
[TBL] [Abstract][Full Text] [Related]
10. Oncologist-patient discussion of adjuvant hormonal therapy in breast cancer: results of a linguistic study focusing on adherence and persistence to therapy.
Davidson B; Vogel V; Wickerham L
J Support Oncol; 2007 Mar; 5(3):139-43. PubMed ID: 17410813
[TBL] [Abstract][Full Text] [Related]
11. A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy.
Hurria A; Hurria A; Zuckerman E; Panageas KS; Fornier M; D'Andrea G; Dang C; Moasser M; Robson M; Seidman A; Currie V; VanPoznak C; Theodoulou M; Lachs MS; Hudis C
J Am Geriatr Soc; 2006 Jul; 54(7):1119-24. PubMed ID: 16866685
[TBL] [Abstract][Full Text] [Related]
12. Retrospective study of the effect of comorbidity on use of adjuvant chemotherapy in older women with breast cancer in a tertiary care setting.
Hawfield A; Lovato J; Covington D; Kimmick G
Crit Rev Oncol Hematol; 2006 Sep; 59(3):250-5. PubMed ID: 16527489
[TBL] [Abstract][Full Text] [Related]
13. Prescription of tamoxifen for breast cancer prevention by primary care physicians.
Armstrong K; Quistberg DA; Micco E; Domchek S; Guerra C
Arch Intern Med; 2006 Nov; 166(20):2260-5. PubMed ID: 17101945
[TBL] [Abstract][Full Text] [Related]
14. Changing practice in systemic breast cancer adjuvant treatment in a well-defined French population.
Chaplain G; Coudert B; Milan C; Altwegg T; Esteve J
Bull Cancer; 1999 Oct; 86(10):855-60. PubMed ID: 10572236
[TBL] [Abstract][Full Text] [Related]
15. Surveillance testing among survivors of early-stage breast cancer.
Keating NL; Landrum MB; Guadagnoli E; Winer EP; Ayanian JZ
J Clin Oncol; 2007 Mar; 25(9):1074-81. PubMed ID: 17369571
[TBL] [Abstract][Full Text] [Related]
16. The influences of age and co-morbidities on treatment decisions for patients with HER2-positive early breast cancer.
Ring A
Crit Rev Oncol Hematol; 2010 Nov; 76(2):127-32. PubMed ID: 20097087
[TBL] [Abstract][Full Text] [Related]
17. Survey of ASCO members on management of sentinel node micrometastases in breast cancer: variation in treatment recommendations according to specialty.
Wasif N; Ye X; Giuliano AE
Ann Surg Oncol; 2009 Sep; 16(9):2442-9. PubMed ID: 19506955
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?
Keating NL; Landrum MB; Klabunde CN; Fletcher RH; Rogers SO; Doucette WR; Tisnado D; Clauser S; Kahn KL
J Clin Oncol; 2008 May; 26(15):2532-7. PubMed ID: 18487570
[TBL] [Abstract][Full Text] [Related]
19. Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ.
Yen TW; Kuerer HM; Ottesen RA; Rouse L; Niland JC; Edge SB; Theriault RL; Weeks JC
J Clin Oncol; 2007 Aug; 25(22):3251-8. PubMed ID: 17577019
[TBL] [Abstract][Full Text] [Related]
20. Decreased use of adjuvant breast cancer therapy in a randomized controlled trial of a decision aid with individualized risk information.
Peele PB; Siminoff LA; Xu Y; Ravdin PM
Med Decis Making; 2005; 25(3):301-7. PubMed ID: 15951457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
